• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性抗氧化剂对急性和慢性精神分裂症患者临床症状和认知功能的影响差异。

Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients.

机构信息

Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

School of Medicine, Chang Gung University, Taoyuan, Taiwan.

出版信息

Int J Neuropsychopharmacol. 2023 Aug 29;26(8):576-583. doi: 10.1093/ijnp/pyad040.

DOI:10.1093/ijnp/pyad040
PMID:37422918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10464923/
Abstract

BACKGROUND

Impaired antioxidant defense is implicated in the pathophysiology of schizophrenia, and superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) are 3 first-line endogenous antioxidants. Various cognitive functions decline differently during the schizophrenia course. The characteristic roles of the 3 antioxidants in clinical and cognitive profiles in acute and chronic phases of schizophrenia require study.

METHODS

We recruited 311 patients with schizophrenia, including 92 acutely exacerbated patients who had been off antipsychotics for at least 2 weeks and 219 chronic patients who had been stable on medication for at least 2 months. Blood SOD, CAT, and GSH levels; clinical symptoms; and 9 cognitive test scores were measured.

RESULTS

Blood CAT levels were higher in the acute patients than in the chronic patients, whereas SOD and GSH levels were similar to one another. Higher CAT levels were correlated with less positive symptoms, better working memory and problem solving in the acute phase, and less negative symptoms, less general psychopathology, better global assessment of function, and better cognitive function (in speed of processing, attention, problem solving) in the chronic period. Higher SOD levels were correlated with better global assessment of function in the acute phase and better speed of processing, working memory, and verbal learning and memory in the chronic period. GSH influenced neither clinical nor cognitive manifestations.

CONCLUSIONS

This study showed that blood CAT affected different clinical and cognitive domains between acute and chronic stages of schizophrenia, SOD influenced cognitive functions in chronic state, but GSH affected none. Further studies are needed to explore the underlying mechanisms.

摘要

背景

抗氧化防御功能受损与精神分裂症的病理生理学有关,超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和谷胱甘肽(GSH)是 3 种主要的内源性抗氧化剂。各种认知功能在精神分裂症病程中下降程度不同。3 种抗氧化剂在精神分裂症急性期和慢性期的临床和认知特征中的作用需要进一步研究。

方法

我们招募了 311 名精神分裂症患者,包括 92 名抗精神病药物停药至少 2 周的急性恶化患者和 219 名药物稳定至少 2 个月的慢性患者。测量了血液 SOD、CAT 和 GSH 水平、临床症状和 9 项认知测试分数。

结果

急性患者的血液 CAT 水平高于慢性患者,而 SOD 和 GSH 水平相似。较高的 CAT 水平与急性期较少的阳性症状、较好的工作记忆和解决问题能力,以及慢性期较少的阴性症状、较轻的一般精神病学症状、较好的总体功能评估和较好的认知功能(在处理速度、注意力、解决问题方面)相关。较高的 SOD 水平与急性期的总体功能评估和慢性期的处理速度、工作记忆和言语学习记忆较好相关。GSH 既不影响临床症状也不影响认知表现。

结论

本研究表明,血液 CAT 影响精神分裂症急性期和慢性期不同的临床和认知领域,SOD 影响慢性期的认知功能,但 GSH 没有影响。需要进一步研究探索潜在的机制。

相似文献

1
Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients.内源性抗氧化剂对急性和慢性精神分裂症患者临床症状和认知功能的影响差异。
Int J Neuropsychopharmacol. 2023 Aug 29;26(8):576-583. doi: 10.1093/ijnp/pyad040.
2
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.利培酮对精神分裂症和分裂情感性障碍的认知及精神运动作用。
Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014.
3
Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs.精神分裂症患者氧化应激标志物的变化:抗精神病药物的影响。
Psychiatry Res. 2013 Oct 30;209(3):284-90. doi: 10.1016/j.psychres.2013.01.023. Epub 2013 Mar 14.
4
Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients.未经治疗和接受治疗的精神分裂症患者体内谷胱甘肽水平及抗氧化酶活性降低。
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1178-83. doi: 10.1016/j.pnpbp.2009.06.018. Epub 2009 Jul 2.
5
The interplay between BDNF and oxidative stress in chronic schizophrenia.脑源性神经营养因子(BDNF)与慢性精神分裂症中氧化应激之间的相互作用。
Psychoneuroendocrinology. 2015 Jan;51:201-8. doi: 10.1016/j.psyneuen.2014.09.029. Epub 2014 Oct 7.
6
Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.氟哌啶醇对精神分裂症患者抗氧化防御系统酶的影响。
J Psychiatr Res. 1998 Nov-Dec;32(6):385-91. doi: 10.1016/s0022-3956(98)00028-4.
7
The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia.银杏叶提取物联合奥氮平对精神分裂症患者治疗效果及抗氧化酶水平的影响
Psychiatry Clin Neurosci. 2005 Dec;59(6):652-6. doi: 10.1111/j.1440-1819.2005.01432.x.
8
Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase in Patients with Schizophrenia.精神分裂症患者红细胞过氧化氢酶和谷胱甘肽过氧化物酶活性降低。
Medicina (Kaunas). 2022 Oct 19;58(10):1491. doi: 10.3390/medicina58101491.
9
Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate.精神分裂症患者使用长效氟哌啶醇癸酸酯治疗后的氧化应激。
Psychiatry Res. 2013 Dec 30;210(3):761-8. doi: 10.1016/j.psychres.2013.08.035. Epub 2013 Sep 13.
10
[Cognition, schizophrenia and the effect of antipsychotics].[认知、精神分裂症与抗精神病药物的作用]
Encephale. 2006 May-Jun;32(3 Pt 1):341-50. doi: 10.1016/s0013-7006(06)76162-0.

本文引用的文献

1
Schizophrenia and oxidative stress from the perspective of bibliometric analysis.从文献计量分析角度看精神分裂症与氧化应激
Front Psychiatry. 2023 Feb 27;14:1145409. doi: 10.3389/fpsyt.2023.1145409. eCollection 2023.
2
Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients.过氧化氢酶和白细胞介素-6血清水平升高对男性精神分裂症患者治疗抵抗的预测作用
Asian J Psychiatr. 2023 Jan;79:103400. doi: 10.1016/j.ajp.2022.103400. Epub 2022 Dec 12.
3
Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease.内源性抗氧化剂可预测预后,并在治疗后增加:一项用于治疗阿尔茨海默病的苯甲酸盐剂量发现、随机、双盲、安慰剂对照试验。
Psychiatry Clin Neurosci. 2023 Feb;77(2):102-109. doi: 10.1111/pcn.13504. Epub 2022 Nov 24.
4
Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis.抗精神病药对精神分裂症患者抗氧化防御系统的影响:一项荟萃分析。
Psychiatry Res. 2022 Mar;309:114429. doi: 10.1016/j.psychres.2022.114429. Epub 2022 Feb 3.
5
A bagging ensemble machine learning framework to predict overall cognitive function of schizophrenia patients with cognitive domains and tests.一种装袋集成机器学习框架,用于预测具有认知领域和测试的精神分裂症患者的整体认知功能。
Asian J Psychiatr. 2022 Mar;69:103008. doi: 10.1016/j.ajp.2022.103008. Epub 2022 Jan 14.
6
Oxidative Stress Biomarkers as a Predictor of Stage Illness and Clinical Course of Schizophrenia.氧化应激生物标志物作为精神分裂症疾病分期和临床病程的预测指标
Front Psychiatry. 2021 Nov 15;12:728986. doi: 10.3389/fpsyt.2021.728986. eCollection 2021.
7
Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits.男性迟发性精神分裂症中超氧化物歧化酶活性升高及其与临床症状和认知功能障碍的相关性。
BMC Psychiatry. 2021 Dec 4;21(1):606. doi: 10.1186/s12888-021-03604-5.
8
Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study.轻度认知障碍(MCI)患者血浆谷胱甘肽水平随认知功能下降而降低:一项为期两年的前瞻性研究。
Antioxidants (Basel). 2021 Nov 19;10(11):1839. doi: 10.3390/antiox10111839.
9
Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.超氧化物歧化酶、脑源性神经营养因子与首发精神分裂症患者认知改善的相关性:一项为期 12 周的纵向研究
Int J Neuropsychopharmacol. 2022 Feb 11;25(2):128-135. doi: 10.1093/ijnp/pyab065.
10
Converting scores between the PANSS and SAPS/SANS beyond the positive/negative dichotomy.将 PANSS 与 SAPS/SANS 评分在正性/负性二分法之外进行转换。
Psychiatry Res. 2021 Nov;305:114199. doi: 10.1016/j.psychres.2021.114199. Epub 2021 Sep 1.